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1718-21 Functional Effects of TNFa Gene Expression in the
Heart
Samir Kapadia, Joseph Lee, Guillermo Torre-Amione, Tony S. Ma, Douglas
L. Mann. VAMC & Baylor Coli. of Med, Houston, 7X
TNFa, a proinflammatory cytokine, has been implicated in the pathogene-
sis of septic shock, viral myocarditis, and congestive heart failure. While
the activated macrophage is thought to be the 10 source for TN Fa produc-
tion, a recent report showed that TNFa mRNA was expressed in the heart.
However, the significance of this finding is not known. Accordingly, the pur-
pose of this study was to determine: (1) which cell types in the heart pro-
duce TNFa mRNA and protein; and (2) whether the TNFa which is produced
is active biologically. Protocol: we stimulated isolated, buffer perfused cat
hearts (n = 8) with lipopolysaccharide (LPS) - a classical stimulus for TNFa
production; control hearts (n = 5) were stimulated with diluent. Northern
blot analysis showed that mRNA for TNFa was detected within 30 min and
peaked at 90 min after LPS stimulation; mRNA forTNFa was not detectable
in control hearts. TNFa protein (>500 U/ml) was detectable by bioassay 60
min after LPS treatment and peaked by 120 min; TNFa protein was not
detectable in control hearts. TNFa contained in the effluent (1:2 dilution)
from the LPS treated hearts produced negative inotropic effects in isolated
contracting feline cardiac myocytes. Immunohistochemical studies of LPS
treated hearts localized TNFa to the cardiac myocytes, endothelial cells and
to vascular smooth muscle cells; control hearts were negative for TNFa im-
munostaining. Subsequent studies employing myocytes and non-myocyte
cell types isolated from LPS stimulated hearts showed that TNFa mRNA and
protein were produced by myocytes and non-myocytes. Conclusion: these
data show for the first time that myocyte and non-myocyte cell types in the
heart can rapidly produce biologically active TNFa which is capable of caus-
ing negative inotropic effects.
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1718-31 Cardiac Overexpression of pARK in Transgenic Mice
Inhibits Isoproterenol Stimulated Contractility In Vivo
Howard A. Rockman, RaeAnn Hamilton, Carmela A. Milano, Lan Mao, Robert
J. Lefkowitz, Walter J. Koch. HHMI, Duke University, Durham, NC; University of
California, San Diego, La Jolla, CA
Heart failure is associated with a desensitization to ,/l-adrenergic receptor
(,/l-AOR) stimulation which may contribute to the loss of cardiac contractility.
This may be due, in part, to receptor uncoupling through phosphorylation of
agonist occupied receptor by the ,/l-adrenergic receptor kinase (,/lARK). Al-
though recent studies have shown increased expression of ,/lARK in human
heart failure, it is unknown whether enhanced expression of ,/lARK would
result in desensitization in the normal heart. Accordingly, transgenic mice
were generated which overexpress ,/lARK (3-5 fold increase) targeted to the
heart with the aMHC promoter. In vivo hemodynamic parameters were ob-
tained in anesthetized intact transgenic (n = 10) and control (n = 8) mice
using a 2F high fidelity micromanometer placed in the left ventricle (LV) at
baseline and after progressive doses of isoproterenol (ISO) (0.005 to 1ng).
Baseline LV dP/dtmax (control 3824 ± 327, transgenic 3594 ± 308, mmHg/s,
p = ns, mean ± SEM) and heart rate (control 370 ± 15, transgenic 343 ± 15,
beatslmin, p = ns) were similar in both groups. In contrast. overexpression
of ,/lARK significantly inhibited the rise in LV dP/dtmax with ISO (1 ng) (control
8410 ± 678, transgenic 6284 ± 645 mmHg/s, p < 0.05). The ISO stimulated
increase in heart rate was also significantly blunted in the transgenic group
(control 430 ± 20, transgenic 376 ± 12 beatslmin, p < 0.05). No difference
in LV pressure between groups was seen with ISO infusion.
In conclusion, cardiac overexpression of ,/lARK had no effect on basal con-
tractility but significantly impaired the inotropic and chronotropic response
to ISO. This suggests that in the normal heart, receptor occupancy by agonist
is a required process for in vivo ,/l-AOR desensitization.
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Lack of Positive Inotropic Effect by p-Adrenoceptor
Stimulation in the Failing Myocardium is not Due to
Inability to Supply Intracellular Ca2+ nor cAMP:
Studies in Dahl Rat Heart Failure Model
Moriaki Inoko, Yasuk, Kihara, Shigetake Sasayama. Third Division, Department of
Internal Medicine, Kyoto University Faculty of Medicine, Kyoto. Japan
We recently reported that the Dahl salt-sensitive rat (OS) fed with a high-
salt diet presents the transition from compensatory LV hypertrophy at the
age of 11 weeks (LVH) to the decompensated LV dilatation at the age of 16-
22 weeks (CHF). To investigate the mechanisms of decreased positive in-
otropic effects of ,/l-adrenoceptor stimulation in the failing myocardium, we
observed the effects of isoproterenol (ISO) (1 0-9_1 0-6M) and forskolin (FORI
(10-7-1 0-5M) on the isometric tension (T) and the corresponding intracel-
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lular calcium transients (Ca~+) in the aequorin-Ioaded LV papillary muscles
from this animal. Control studies were performed in 18-week-old Dahl salt-
resistant rats (DR). In LVH, OS showed a significant prolongation in the time
course of T without changes in that of Cat+. In CHF, peak T was depressed
and the time course of T was further prolonged, which was accompanied
by a reduced amplitude and a prolonged time course of Cat+ The positive
inotropic effect (increase in peak T) by ISO was decreased in LVH and disap-
peared in CHF despite preserved augmentation of peak CaF+ in both stages.
In contrast, FOR increased both peak T and peak CaF+ in either stage.
ISO 110-5 M) ISO 110-5 M) FOR110- 5 M) FOR (10-5 M)
%peakT %peakCaf+ %peakT %peakCaf+
DR 6 189 ± 34 202 ± 36 284 ± 72 301 ± 69
LVH OS 6 146 ± 21' 182 ± 32 196± 17' 282 ± 43
CHF DS 6 83 ± 24'" 158±21' 173 ± 52' 248 ± 44
means ± S.D.; %peakT: %change in peakT; %peakCa~+: %change in peakCa~+; *p <
005, "p < 001 vs. DR. t P < 0.05, 'p < 0.01 vs. LVH DS
Conclusions: Intracellular calcium handling was altered considerably dur-
ing the transition from LVH to CHF. However, the discrepancy between the
inotropic effect by ISO and that by FOR in CHF was not due to inability to
supply Ca2+ for myofilaments. The results suggest ISO-specific desensitiza-
tion of myofilaments for Ca2+ in CHF muscle, which may be mediated by
,/l-receptor/G-protein systems but not by adenylate cyclase activation.
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Differential Regulation of Phosphorylase Kinase in
Failing Human Left Ventricular Myocardium
Glenn E. Meixell, Wendy P. Wangsgaard, Donald K. Blumenthal, Michael
R. Bristow. University of Colorado Health Sciences Center. Denver. Colorado
Congestive heart failure is characterized by a hyperadrenergic state and in-
creased intracellular Ca++ levels in failing human ventricular myocardium.
Phosphorylase kinase is a key enzyme in the ,/l-adrenergic pathway and is
primarily regulated by cyclic AMP dependent protein kinase and calcium. In
the case of phosphorylase kinase in failing human heart, an increase in ,/l-
adrenergic drive and intracellular Ca++ would be expected to increase the
rate of glycogenolysis, leading to a depletion of glycogen. However, glyco-
gen stores appear to increase in failing as compared to nonfailing human left
ventricular myocardium (unpublished observations). Therefore, we tested
the hypothesis that in heart failure, the hyperadrenergic state results in dif-
ferential regulation of phosphorylase kinase in failing human ventricular my-
ocardium. An enzymatic assay of [y_32pJ ATP was used to measure the rate
of incorporation of 32p into the endogenous substrate of phosphorylase ki-
nase, phosphorylase b. We have shown that phosphorylase kinase in crude
extracts from failing (IOC, n = 10) human left ventricular myocardium has a
specific activity (nmol/min·mg) that is twofold higher than in nonfailing (n =
8) left ventricular myocardium (0.09 ± 0.016 vs. 0.22 ± 0.02 nmol/min.mg,
p < ODS'). Moreover, activation of the enzyme in failing heart upon binding
an antibody raised to the N-terminal region of the catalytic subunit results in
higher specific activities than nonfailing heart (DAD ± 0.09 vs. 0.64 ± 0.16
nmol(min·mg, p < 0.05"), suggesting altered function within the regulatory
subunits. These results support the hypothesis that in failing human heart,
phosphorylase kinase is differentially regulated. Moreover, these results in-
dicate that in failing myocardium, other downstream enzymatic processes
in the glycogenolytic pathway may be affected, such as phosphorylase b to
a conversion, which prevent appropriate glycogen turnover under the influ-
ence of increased adrenergic drive.
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1718-61 Immunohistochemical Localization of Growth Factors
in the Human Failing Myocardium
Doris Haab, Patrick Franzen, Mohammad Mehrabi, Karina Plesch, Ingrid Pribill,
Michael Grimm, Hans-Georg Eichler, Gunter Klappacher. University of Vienna,
Vienna, Austria
The expression of growth factors was analysed by immunohistochemistry
in 25 explanted human hearts with endstage cardiomyopathy obtained at
the time of transplantation surgery (12 idiopathic 110 ischemic 13 valvular
heart disease). The aim of this study was to assess the relation between
distribution of growth factors and fibrosis and microvessel formation in the
myocardium. Basic fibroblast growth factor (bFGF) was predominantly lo-
calized in the extracellular matrix, reflected by the significant correlation be-
tween morphometric area fractions of collagen type I and bFGF (R = 0.6,
p < 0.05). In terms of cellular distribution, bFGF was strongly expressed on
vascular smooth muscle cells of small intramural coronary arteries, as de-
tected by double immunostaining with a fluorescence-conjugated antibody
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against smooth muscle alpha actin. Capillary endothelial cells (stained with
an antibody against von Willebrand factor, vWF) showed only weak colocal-
ization with bFGF so that the relationship between the morphometric area
fractions of vWF and bFGF was even inverse (R = -0.662, p = 0.0005). Sim-
ilarly to bFGF, intense immunolabeling of platelet derived growth factors AA
and SS (PDGFs) was observed on vascular smooth muscle cells, whereas its
correlation with the vWF-staining of capillary endothelial cells was inverse (R
= -0.387, p < 0.025). PDGFs were not detected in the extracellular ma-
trix. In contrast to bFGF and PDGFs, transforming growth factor-,8 (TGF-,8)
was primarily associated with vWF-positive capillary endothelial cells. The
extracellular matrix contained TGF-,8 in areas of scarring and repair. Conclu-
sion: In the failing myocardium, TGF,8 is primarily expressed on the capillary
endothelium, wheras PDGFs and bFGF are more associated with the vas-
cular smooth muscle cells of intramural coronary arteries. In addition, large
amounts of bFGF are bound to collagen type 1. These distinct patterns of
distribution of growth factors suggest a network of feedback mechanisms
involving different cell types and the extracellular matrix during ventricular
remodeling.
~ Syncope and Sudden Cardiac Death: Clinical
Predictors, Tilt Testing, and Electrophysiologic
Testing
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1719-1 I Does Vasodepressor Syncope Require Normal
Ventricular Function?
Andrea Natale, Jasbir Sra, Anwer Dhala, Michael Biehl, Abdul Wase,
Sanjay Deshpande, Cheryl Maglio, Margaret Budziszewski, Masood Akhtar. SInai
Samaritan/St. Luke's Medical Center, Milwaukee, WI
Vasodepressor syncope is believed to be preceded by hypercontractility
which leads to mechanoreceptor stimulation. Therefore, a preserved left ven-
tricular function is supposedly required to trigger the reflex. We analyzed our
experience in patients with positive head-up tilt test. Out of 500 patients 32
had previous history of structural heart disease. Of them 8 patients had se-
vere left ventricular dysfunction (EF < 30%). The mean age was 52 ± 8 years,
5 were male and 3 female. Mean EF was 22 ± 5%. Six patients had dilated
cardiomyopathy and 2 had myocardial infarction. Electrophysiologic study
was negative in 6 patients while the remaining two had inducible sustained
monomorphic ventricular tachycardia requiring defibrillator implant. Syncope
was witnessed by physicians in 6 out of 8 patients and was associated with
bradycardia and hypotension. In all8 patients head-up tilt reproduced symp-
toms. Upright tilt was positive at baseline in 7 patients and during isopro-
terenol infusion in 1 patient. Five patients were treated with theophylline, 1
with ephedrine, and 2 with disopyramide. After a mean follow-up of 2.2 ±
1.3 years all 8 patients were free of vasodepressor-related syncope.
Conclusion: We conclude that vasodepressor syncope is possible even
in the presence of severely impaired ventricular function and should, there-
fore, be entertained in such cases. Alternative mechanisms may mediate the
circulatory response in this population.
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1719-21 Evolution of Patients with Neurocardiogenic
(Vasovagal) Syncope not Subjected to a Specific
Treatment
Aurora Ruiz, Adelqui Peralta, Eleonora Duce, Jorge Scaglione,
Jorge Gonzalez-Zuelgaray. Argerich Hospital, Buenos Aires, Argentina
The results obtained with some drugs or other therapeutic strategies in the
prevention of neurocardiogenic syncope are encouraging. However, the ben-
efit they represent when compared with the natural history of this disorder
has not been clearly established. The purpose of this prospective study was
to analyze the natural history of patients with neurocardiogenic syncope.
Fifty-six consecutive patients with either: a) One or more episodes of syn-
cope and a positive head-up Tilt test (29 patients), or b) Typical history of
neurocardiogenic (vasovagal) syncope (27 patients) despite a negative Tilt
test, were followed up by telephone or personal consultation during a mean
period of 16.1 ± 10.2 months. Patients were discharged without any specific
medication.
There were no deaths during the follow-up period. Recurrences were
found in 5 patients (8.9%). The risk of recurrence was 7% after one year
and 15% after 21 months. The multivariate analysis showed the duration of
symptoms before the inclusion as an independent variable related to recur-
rences (p < 0.025).
Conclusions: The prognosis of patients with neurocardiogenic syncope is
excellent as far as survival is concerned. Recurrences of episodes without
any specific treatment are uncommon after diagnosis has taken place. This
finding strengthens the need to evaluate the effect of drugs with placebo
control groups and to select the highest risk group for treatment.
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Usefulness of Signal-Averaged ECG, Head-up Tilt
and Eleetrophysiologic Studies in Patients with
Unexplained Syncope
Carlos A. Morillo, Sally Zandri, George J. Klein, Raymond Vee. McGuire VA Medical
Center, Richmond, VA: University Hospital, London, Ontario, Canada
The recent availability of non-invasive diagnostic methods such as signal-
averaged ECG (SAECG) and Head-up tilt (HUT) have raised the need to evalu-
ate the role of such tests for the screening of pts with recurrent unexplained
syncope (US). The purpose of the present study was to identify the clini-
cal variables that predicted an abnormal SAECG and HUT in a series of 70
consecutive pts. referred for assessment of recurrent US. SAECG (ART EPX
1200) and HUT @ 60° with a low-dose isoproterenol protocol for 30 minutes,
were performed in all pts. SAECG was considered (+) if ?;2 of Simson crite-
ria were abnormal. A (+) HUT was defined as the induction of presyncope or
syncope associated with bradycardia and hypotension that resembled the
clinical episode. All pts underwent 2D-echo, radionuclide angiography and
electrophysiologic study (EPS).
VT(+) SAECG(+) SAECG(-) HUl(+) HUll-) EPS
N Pts 24 (34%) 46 (64%) 30(42%) 40 (57%) 29{41%)
AGE 42 ± 12 45 ± 16 36 ± 10' 55 ± 10' 45 ± 15
EF% 34 ± 8' 53 ± 6 55 ± 9 53 ± 5 36 ± 5'
PMI 16(67%)' 4(9%) 2(6.6%) 2(5%) 19 (66%)'
EF = Eyection fraction. PMI = Previous myocardial infarction. * = MultivariabJe analysis
p<OO1
A (+) SAECG, previous MI and EF < 40% were highly predictive (95%) of
induction of sustained monomorphic VT during EPS. Similarly, (-) SAECG
and age < 50 yrs were associated with a (+) HUT in 96%. Overall a cause
for US was determined in 77%.
Conclusions: A (+) SAECG, EF < 40% and history of a previous MI were
highly predictive of the induction of VT during EPS in pts with US. A (-)
SAECG, EF > 40% and age> 50 yrs were predictive of a (+) HUT. Non-
invasive screening of pts with US with SAECG and HUT increased the di-
agnostic yield and should be performed prior to invasive assessment with
EPS.
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1719-41 RR Variability Preceding Head Up Tilt Predicts
Syncope in Children
Julian M. Stewart, Markus Erb, David Rubin, Carmine Sorbera. New York Medical
College, Valhalla, NY
To assess RR variability during head up tilt (HUT) we studied 20 syncopal pts
aged 7-18y with Holter monitor. After 30 min supine, pts were tilted to 80°
for 30 min or until syncope occurred. Sequential 256 and 512 beat epochs
free from ectopy were analyzed. Mean and standard deviation, root mean
square (RMSSD), fraction exceeding 50 msec (pN50) and correlation coeffi-
cient (r) of successive differences were computed. An autoregressive power
spectrum model was used. Low frequency power (LFP. 0.05-0.15 Hz). high
frequency power (HFP. 0.15-040 Hz), and total power (TP. 0.01-0.40 Hz) were
compared. Epochs while supine, within 5 minutes after HUT, 5--10 min after
HUT, and 15 min after or during syncope were analyzed. 12 pts fainted (F)
and B did not (N). RR interval was 910 ± 6 for Nand 870 ± 4 msec for F
(p = NS). Indices of RR variability were markedly different (p < 0.05) for F
and N while supine: RMSSD was 128 ± 22 for N vs 62 ± 7 msec for F. pN50
was 0.51 ± 0.06 for N vs 0.33 ± 0.04 for F, r was 0.50 ± 0.06 for N vs 0.70
± 0.05 for F. LFP was 920 ± 140 in N vs 1710 ± 440 msec2 in F (p = NS),
while HFP and TP were 2990 ± 840 and 7062 ± 1500 in N vs 834 ± 130
and 2855 ± 420 msec2 in F (p < 0.05). With HUT RR decreased similarly in
F and N (25 ± 3% and 26 ± 3%) while RMSSD and pN50 decreased pro-
portionately in N (by 59 ± 5% and 63 ± 10%) and in F (by 59 ± 4% and
83 ± 5%, p = NS). RMSSD and pN50 remained higher in N vs F after tilt. r
increased for N (to 0.77 ± 0.05) and F (to 0.88 ± 0.02) but remained higher
in F reflecting lower variability. LFP. HFP. and TP decreased proportionately
for each group. Thus HFP and TP remained higher in N than F. Similar results
were obtained after 5--10 minutes of HUT in Nand F and after 15 minutes in
N. In F prior to syncope, RR increased to 1,045 ± 50 msec, RMSSD to 125 ±
25 msec, PN50 to 0.41 ± 0.05, and r fell to 0.51 ± 0.04, while TP increased
to 5200 ± 1343 msec2, LFP increased to 1717 ± 601 msec2, and HFP in-
creased to 2730 ± 1075 msec2. Relatively decreased RR variability supine
